Delivery Order SPE2DB22D1106-SPE2DB24FETR2
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,965.74 firm fixed-price delivery order contract is for the provision of 100 ml bottles of 2% lidocaine viscous solution. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award, valued at $2,823.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lidocaine 2% Viscous Solution in 100ml containers, a medical product used for various healthcare applications. The contract is a firm fixed-price delivery order with a period of performance through March 2024. This award is part of Amerisourcebergen's broader...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562655056 - Lidocaine 2% Viscous Solution, 100 ML, with a ceiling value of $1,994.40 and a performance period through November 1, 2023. This is a firm fixed price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $1,070.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567130613 - Lidocaine 2% Viscous Solution 100ML, a medical product used in various healthcare settings. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 4, 2025. It is not designated as a...
- This federal contract award, valued at $2,419.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 2% Viscous Solution, a pharmaceutical product, to support military and federal healthcare programs. The contract has an ultimate completion date of November 17, 2023, and is a Firm Fixed Price Delivery Order. The award is associated with a larger...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100ml bottles of 2% Lidocaine Viscous Solution, with a ceiling value of $4,968.40. The contract type is a Delivery Order under a Firm Fixed Price pricing arrangement. The period of performance extends through May 20, 2025. This award is not set-aside and appears to be part of a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation. The award is for $1,186.34 to supply 100mL bottles of 2% Lidocaine Viscous solution. The contract has a firm fixed price pricing type and an ultimate completion date of September 4, 2024. This order is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.58 to AmerisourceBergen Drug Corp for the supply of Lidocaine 2% Viscous Solution in 100ml quantities. This contract, awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a firm fixed-price procurement with no set-aside designation. The award was competitively executed and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,123.68, is for the delivery of Lidocaine 2% Viscous Solution, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,501.89 firm fixed price delivery order is for the supply of 4564380686 - Lidocaine 2% Viscous Solution in 100 ML containers. This contract has no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FETR2Delivery Order
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FETR2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,064.54 firm fixed-price delivery order is for the supply of 100ml bottles of 2% Lidocaine Viscous Solution, a medical product used for various healthcare applications. The contract has an ultimate completion date of May 28, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award does not have a set-aside designation, indicating it was awarded through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 5/24/24 |